Earnix, the Category Leader in Dynamic AI for the Insurance Industry, Acquires Zelros to Transform Insurers’ Business Performance
29.4.2025 15:10:00 EEST | Business Wire | Press release
Earnix, the leading Dynamic AI platform for Insurance, today announced that it has signed a definitive agreement to acquire Zelros, a pioneer in Generative AI for insurers and banks. This innovative collaboration will bring the power of predictive, generative, and agentic AI across the entire risk decisioning, personalization, and claims cycle, thereby enabling pricing and underwriting professionals to deliver compelling offers while improving business performance.
By combining Earnix’s advanced Predictive AI platform with Zelros’s GenAI recommendations engine, providers can now present the right offer, at the right price, at the right time. The joint offering provides precise decision-making at scale in regulated environments for pricing and product managers, underwriters, and agents, ultimately resulting in higher conversion rates with better customer engagement and satisfaction.
Both companies bring demonstrated impact in supporting leading insurers and banks across the globe, including Aviva, AXA, BPCE, IAG, Generali, Matmut, Santander, and Tokio Marine. "As a mutual customer of Zelros and Earnix, we’re excited about the acquisition,” shared Stéphane Muller (Chief Insurance Officer) and David Quantin (Chief Information Officer) of Matmut. “The synergies between the two are compelling and will help us better meet our members' coverage needs and experiences."
"We are pleased to announce Earnix’s acquisition of Zelros, a strategic move that reaffirms us as the technology leader driving responsible AI innovation,” cited Robin Gilthorpe, CEO of Earnix. “Furthermore, we are strengthening our presence in France by establishing a key development center for the company in this critical market. We are excited about this new chapter and the immense potential it unlocks for our customers and partners."
“With the integration of our leading predictive and generative AI capabilities, we aim to reshape the customer experience by providing personalized, data-driven interactions that build confidence and drive retention,” added Damien Philippon, Co-founder and CEO of Zelros. “Our shared commitment to continuous innovation ensures that together, Earnix and Zelros will lead the way in delivering best-in-class solutions for the insurance and banking sectors.”
Dr. Erel Margalit, the Chairman of Earnix and multiple other innovative companies, including, formerly, CyberArk (Nasdaq: CYBR), says “Over the last few years, Earnix has established itself as the preeminent AI platform for Pricing, Rating, and Insurance Operations across more than 35 countries. Working with core systems providers, such as Guidewire, Earnix is the complementary AI platform which allows for dynamic, data-driven responses to changing market conditions. France has been a key focus for us as we expand our European operations, and we are delighted to have Zelros and the team join us in Paris.”
Earnix and Zelros are committed to reshaping the future, driving innovation that delivers business impact. This acquisition represents a significant leap forward in harnessing the full power of AI designed specifically to meet the evolving demands of insurers, banks, and the customers they serve.
About Earnix
Earnix is the premier provider of mission-critical, intelligent decisioning across pricing, underwriting, rating, and product personalization. Its fully integrated platform provides ultra-fast ROI and is designed to transform how global insurers and banks are run by unlocking value across all facets of the business. Earnix has been innovating for insurers and banks since 2001, with customers in over 35 countries across six continents and offices in the Americas, Europe, Asia Pacific, and Israel. Earnix is backed by investors JVP and Insight Partners.
To learn more, visit: www.earnix.com.
About Zelros
Zelros is a pioneer and award-winning InsurTech. Its GenAI-driven recommendation engine is transforming insurance distribution by enabling a unique customer and agent experience through hyper-personalized insurance recommendations across channels. Zelros is trusted by some of the world’s largest insurance companies, including AXA, BPCE, Groupe Prévoir, MAIF, and Matmut, to help them stay competitive, boost client acquisition and satisfaction, and adhere to Responsible AI governance.
More information on: www.zelros.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250429126257/en/
Contacts
Media Relations, Earnix
press@earnix.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the Region8.6.2026 07:00:00 EEST | Press release
BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA’s established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA’s Broker-Dealer license from Dubai’s Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA’s regulated product suite under VARA’s oversight, marking another step in the region’s continued buildout of institutional digital asset infrastructure amid growing demand for integrated execution and custody solutions. “The Middle East and North Africa has quickly become one of the most exciting regions in the world for digital assets, with regulators, institutions, and innovators moving with real purpose,” said Mike Bels
Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 14:00:00 EEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 13:41:00 EEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom